Category - Pharma Industry News
Pfizer’s JAK inhibitor Xeljanz shows benefit in COVID-19 pneumonia
Researchers identify new drug class with potential in BRCA-mutated tumours
Gov’t announces £36m AI research funding boost for NHS
Kite partners with Shoreline Biosciences to develop allogeneic cell therapies
Fishawack Health acquires digital marketing agency closerlook
PureTech adds potential IBD therapeutic to pipeline after buying out Alivio Therapeutics
Biogen discontinues clinical development of anti-tau antibody for Alzheimer’s disease
Disappointing results from CureVac’s COVID-19 vaccine as phase 2/3 study shows only 47% efficacy